This month, Hoosier Cancer Research Network highlights the Providence Cancer Institute in Portland, Ore., as a featured member of our network.

Rachel E. Sanborn, MD, is a medical oncologist at Portland Cancer Institute and is a member and co-chair of the HCRN Thoracic Clinical Trial Working Group.

Research Interests:

As director of the Phase I Clinical Trials Program at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in Portland, Ore., Dr. Sanborn leads one of the largest portfolios of early-phase cancer clinical trials on the West Coast. As a board-certified medical oncologist and co-director of the Providence Thoracic Oncology Program, she is an active investigator of numerous studies of immunotherapies, targeted therapies, and combination therapies for patients with lung cancer. She is a member of several groups, including the American Society of Clinical Oncology, the Society for Immunotherapy of Cancer, the International Association for the Study of Lung Cancer, and the Lung Cancer Research Foundation, and she is co-chair of the Hoosier Cancer Research Network Thoracic Clinical Trial Working Group.

Educational background:

• MD, Oregon Health & Science University, Portland, Ore.
• Residency (Internal Medicine): University of Illinois, Chicago, Ill.
• Fellowship (Hematology/Oncology): Oregon Health & Science University, Portland, Ore.

Little-known facts:

• Dr. Sanborn is a Portland native.
• Dr. Sanborn has a Great Pyrenees named Madeline.
• Dr. Sanborn enjoys cooking and knitting.

About Hoosier Cancer Research Network:

Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has conducted more than 210 trials in a variety of cancer types and supportive care, resulting in more than 350 publications. More than 8,500 subjects have participated in Hoosier Cancer Research Network clinical trials.